Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.


Material from 2004:
  • 3888 Abstracts
  • 555 Slide presentations
  • 20 Webcasts
  • 96 Handouts
Material from 2004:  Show

Current treatments for allergic rhinitis and asthma

Thematic Poster Session
Chairs: G. D'Amato (Naples, Italy), I. Pavord (Leicester, United Kingdom)
Efficacy of levocetirizine in perennial allergic rhinitis (PAR) as measured by the number of comfortable days
A. Didier (Toulouse, France)
Congress or journal article abstract
Congress or journal article abstract
The efficacy of desloratadine in the treatment of allergic rhinitis
N. I. Kavlashvili, M. N. Kherkheulidze, I. A. Chkhaidze, L. A. Chilachava, S. Broladze (Tbilisi, Georgia)
Congress or journal article abstract
Congress or journal article abstract
Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis
R. F. Hosseini, J. Ghaffari, F. F. Hosseini, F. Jabbari, A. Rahimzadeh (Mash-had, Tehran, Iran)
Congress or journal article abstract
Congress or journal article abstract
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
T. Morali, Z. Karakurt, H. Turker, B. Kos, C. Gedik (Istanbul, Turkey)
Congress or journal article abstract
Congress or journal article abstract
Inhaled steroids in the treatment of newly detected asthma
I. J. Stankovic, T. A. Pejcic, D. V. Djordjevic, M. H. Rancic, L. M. Ristic (Nis, Serbia & Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Efficacy, safety and cost of using beclomethason dipropionate in patients with persistent moderate bronchial asthma
L. A. Botvinikova, T. O. Pertseva, L. I. Konopkina, T. V. Kireeva (Dniepropetrovsk, Ukraine)
Congress or journal article abstract
Congress or journal article abstract
The effects of fluticasone propionate in asthmatic patients
S. Arbutina, D. Dokic, S. Pejkovska, D. Karkinski, Z. Arsovski (Skopje, Macedonia)
Congress or journal article abstract
Congress or journal article abstract
The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT
J. G. Koopmans, R. Lutter, H. M. Jansen, J. S. van der Zee (Amsterdam, The Netherlands)
Congress or journal article abstract
Congress or journal article abstract
The effectiveness of seretide in children with bronchial asthma
M. N. Kherkheulidze, N. I. Kavlashvili, N. V. Sapanadze, M. A. Lominadze, I. V. Chikovani (Tbilisi, Georgia)
Congress or journal article abstract
Congress or journal article abstract
Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma
S. K. Agarwal (Varanasi, India)
Congress or journal article abstract
Congress or journal article abstract
Equivalence of salmeterol (S)/fluticasone propionate (FP) combination with S and FP from separate inhalers as determined by sGaw in Japanese and Caucasian asthmatics
M. Kawai, Y. Takemoto, K. Hashimoto, N. Aoyagi, Y. Nishioka, S. L. Stone, A. Gibson, R. D. Kempsford, J. Lotvall (Kyoto, Tokyo, Japan; Greenford, United Kingdom; Goteborg, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Efficacy and safety of inhaled corticosteroid‘s (ICS) and long-acting beta-agonist‘s (LABA) combination in asthma (A) patients
T. O. Pertseva, L. I. Konopkina, K. Y. Gashynova, T. V. Kirejeva, L. A. Botvinikova (Dnipropetrovsk, Ukraine)
Congress or journal article abstract
Congress or journal article abstract
Salmeterol/fluticasone propionate combination (50/250 μg) twice daily provides better outcomes than alternative asthma therapies – results of the German ‘real life’ study
D. Nowak, T. Volmer, M. Trautmann, J. T. Tews (Munich, Germany)
Congress or journal article abstract
Congress or journal article abstract
Long-term treatment with a leukotriene antagonist
S. Kyoh, K. Asai, Y. Ichimaru, K. Otani, T. Yoshikawa, H. Kamoi, H. Kanazawa, K. Hirata, J. Yoshikawa (Osaka, Japan)
Congress or journal article abstract
Congress or journal article abstract
Low-dose inhaled glucocorticoids are more effective tham LTRA in improving functional data in asthmatics
E. Bacci, M. Zingoni, S. Cianchetti, F. L. Dente, A. Di Franco, E. Garbella, M. Tonelli, P. L. Paggiaro (Pisa, Italy)
Congress or journal article abstract
Congress or journal article abstract
Healthcare resource use following addition of montelukast to budesonide compared to doubling the dose of budesonide in patients with inadequately controlled asthma (COMPACT trial)
D. B. Price, Q. Zhang, V. Sazonov Kocevar, P. G. Polos, D. D. Yin (Aberdeen, United Kingdom; Whitehouse Station, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Efficacy of montelukast as complementary therapy to fixed association ICS/LABA in asthma
R. Peche, E. Potvin, D. Korn, A. Lachman, J. Gusman, M. Dramaix, L. Dupont (Brussels, Belgium)
Congress or journal article abstract
Congress or journal article abstract
Health care resource utilization following addition of montelukast or salmeterol to fluticasone in patients with inadequately controlled asthma (IMPACT trial)
L. Bjermer, V. S Kocevar, Q. Zhang, D. D. Yin, P. G. Polos (Lund, Sweden; Whitehouse Station, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate-severe persistent asthma
C. Z. Wang, Y. Wang, K. X. Lin, J. P. Wang, Z. Q. Zao (Chongqing, China)
Congress or journal article abstract
Congress or journal article abstract
A review of asthma management in a university based clinic
N. L. Rider, T. J. Craig (Hershey, United States Of America)
Congress or journal article abstract
Congress or journal article abstract